Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer (Q29617440)
scientific article (publication date: February 2002)
Language:
Current Data About Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer
(P31) (Q13442814)

(P304) 719-26
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

(P407) (Q1860)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

(P433) 3
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

(P478) 20
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

(P577) Friday, February 1, 2002
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

(P921) (Q61643320)
(P887)

(Q12859063)
(P887)

(Q412616)
(P887)

(P1433) (Q400292)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

(P1476) "Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer" (language: en)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

(P2093) Vogel CL
(P1545) 1
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

Cobleigh MA
(P1545) 2
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

Tripathy D
(P1545) 3
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

Gutheil JC
(P1545) 4
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

Harris LN
(P1545) 5
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

Fehrenbacher L
(P1545) 6
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

Slamon DJ
(P1545) 7
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

Murphy M
(P1545) 8
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

Novotny WF
(P1545) 9
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

Burchmore M
(P1545) 10
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

Shak S
(P1545) 11
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

Stewart SJ
(P1545) 12
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

Press M
(P1545) 13
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11821453
(P813) Sunday, April 30, 2017

other details
description scientific article (publication date: February 2002)

External Links
(P356) 10.1200/JCO.2002.20.3.719
10.1200/JCO.20.3.719
(P698) 11821453
(P3181) 908797